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Upon priming with Candida albicans or with the fungal cell wall component -glucan, monocytes respond with an increased
cytokine production upon restimulation, a phenomenon termed “trained immunity.” In contrast, the prestimulation of mono-
cytes with lipopolysaccharide has long been known to induce tolerance. Because the vast majority of commensal microorgan-
isms belong to bacterial or viral phyla, we sought to systematically investigate the functional reprogramming of monocytes in-
duced by the stimulation of pattern recognition receptors (PRRs) with various bacterial or viral ligands. Monocytes were
functionally programmed for either enhanced (training) or decreased (tolerance) cytokine production, depending on the type
and concentration of ligand they encountered. The functional reprogramming of monocytes was also associated with cell shape,
granulocity, and cell surface marker modifications. The training effect required p38- and Jun N-terminal protein kinase (JNK)-
mediated mitogen-activated protein kinase (MAPK) signaling, with specific signaling patterns directing the functional fate of the
cell. The long-term effects on the function of monocytes were mediated by epigenetic events, with both histone methylation and
acetylation inhibitors blocking the training effects. In conclusion, our experiments identify the ability of monocytes to acquire
adaptive characteristics after prior activation with a wide variety of ligands. Trained immunity and tolerance are two distinct
and opposing functional programs induced by the specific microbial ligands engaging the monocytes.
More than 3 decades ago, a number of studies reported en-hanced immune responses upon reinfection in diverse in-
vertebrate taxa that do not possess adaptive immunity, such as
cockroaches (1–3), shrimp (4, 5), and mealworm beetles (6). In-
terestingly, invertebrates also have proven to be able to mount
enhanced secondary immune responses (7) and to transmit pro-
tection to their offspring (8). While this protection is nonspecific,
several studies demonstrated that these effects enable discrimina-
tion between different classes of pathogens. Recently, Witteveldt
et al. (9) showed that such immune memory can be used in the
vaccination of invertebrates. Whereas vertebrates use somatic re-
arrangement of immunological receptors to induce adaptive im-
mune responses, one mechanism employed by the host defenses
of invertebrates to confer adaptation to infection is alternative
splicing of pattern recognition genes, such as Down syndrome cell
adhesion molecule, which generates a highly diverse set of
31,000 potential alternative splice forms (10, 11). These two
molecular processes have the same consequence: they create a re-
ceptor repertoire that is sufficiently diverse for discriminating be-
tween the broad varieties of different antigens.
The function of prototypic mammalian innate immune cells,
such as NK cells, can also be enforced, leading to protection
against reinfection with viral pathogens (12–15). Similarly, mono-
cytes and/or macrophages exhibit memory characteristics that
mediate protective effects after a second encounter with a patho-
gen (16, 17). We have termed this phenomenon “trained immu-
nity,” defined as enhanced nonspecific innate immune protection
that is suggested to be mediated by epigenetic mechanisms (18). In
contrast to trained immunity, engagement of the Toll-like recep-
tor 4 (TLR4) by lipopolysaccharide (LPS) has been known for
several decades to inhibit the cell function in a process called LPS-
induced tolerance (19, 20). LPS tolerance is an active process
involving epigenetic remodeling (21), and this process has been
suggested to be the basic mechanism responsible for the immuno-
paralysis that occurs after Gram-negative sepsis (22).
Despite the importance of both LPS tolerance (19, 20) and
trained immunity (16, 17), very little is known about the modu-
latory characteristics of the various classes of pattern recognition
receptors and microbial ligands. The aim of this study was to sys-
tematically investigate the potential to either train or induce tol-
erance of the well-known classes of PRRs expressed on mono-
cytes/macrophages, as depicted in Table 1. We demonstrate that
several bacterial, fungal, and viral ligands induce the functional
reprogramming of monocytes, leading to either nonspecific en-
hanced (training) or diminished (tolerance) cytokine production
upon secondary stimulation, a process that is often dependent on
ligand concentration. Understanding the nature of the signaling
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pathways in determining the functional fate of innate host re-
sponses upon sequential stimulation of pattern recognition recep-
tors may represent an important step toward understanding bac-
terial and fungal colonization and/or invasion of the mucosa on
one hand, and for developing novel immunotherapeutic strategies
on the other hand.
MATERIALS AND METHODS
Blood samples. Blood samples were collected from healthy volunteers at
the Sanquin Blood Supply in Nijmegen, the Netherlands. Informed con-
sent was obtained from the volunteers included in the study. Human
peripheral blood mononuclear cells (PBMCs) were isolated from buffy
coats.
Reagents. The culture medium used was Roswell Park Memorial In-
stitute (RPMI) 1640 Dutch modifications from Sigma-Aldrich, supple-
mented with 1% gentamicin, 1% L-glutamine, and 1% pyruvate (Life
Technologies, Nieuwerkerk, the Netherlands).Candida-glucan was iso-
lated and purified as previously described (23). Other reagents were ob-
tained as follows: Pam3CSK4 (product code L2000; EMC microcollec-
tions), LPS (Escherichia coli serotype 055:B5; Sigma-Aldrich) with an
additional purification step (24), flagellins from Salmonella enterica
subsp. enterica serovar Typhimurium FLA-ST, CpG type C oligodeoxy-
nucleotide (ODN) M362, L-Ala--D-Glu-mDAP (Tri-DAP), and R848
(InvivoGen), poly(I·C) (Brunswick, USA), Syk inhibitor (catalog no.
574711; EMD Millipore), p38 inhibitor SB-202190 (product no. S7067;
Sigma-RBI), extracellular single-regulated kinase (ERK) inhibitor (prod-
uct no. V1121; Promega), and Jun N-terminal protein kinase (JNK) in-
hibitor SP600125 (product no. S-2022; AG Scientific, Inc.), phorbol
myristate acetate (PMA)(Sigma), CD45-PC7 (Beckman Coulter), CD68-
antigen-presenting cell (APC) (BioLegend), CD14-phycoerythrin (PE)
(Beckman Coulter), CD11b-fluorescein isothiocyanate (FITC) (Beckman
Coulter), and DC-SIGN (BioLegend). Versene solution was purchased
from Invitrogen, and the CytoTox nonradioactive assay was purchased
from Promega. The Syk inhibitor was used previously, as described (16).
The epigenetic inhibitors, used previously (16, 17), were as follows:
histone methyltransferase inhibitor (5=-deoxy-5=-methylthioadenosine
[MTA]) (product no. D5011; Sigma-Aldrich), epigallocatechin-3-gallate
(EGCG) histone acetyltransferase inhibitor (HAT-i) (product no. E4143;
Sigma), histone demethylase inhibitor (pargyline, product no. P8013;
Sigma-Aldrich), and histone deacetylase inhibitor ITF2357/9 (Ital-
farmaco SpA) (25, 26).
Stimulation experiments. Mononuclear cells were isolated by density
centrifugation of phosphate-buffered saline (PBS)-diluted blood (dilu-
tion 1:1) over a Ficoll-Paque Plus gradient (GE Healthcare). PBMCs were
washed 3 times with PBS and suspended in RPMI 1640 culture medium
supplemented with 1% gentamicin, 1% pyruvate, and 1% L-glutamine.
Cells were counted in a Coulter counter (Coulter Electronics), and the
concentration was adjusted to 5  106 cells/ml. For stimulation experi-
ments, a 100-l suspension of 5  105 PBMCs in RPMI medium was
added to flat-bottomed 96-well plates (Greiner Bio-One) and incubated
for 1 h at 37°C and 5% CO2. The adherent monocytes were selected by
washing out nonadherent cells three times with warm PBS. For training,
the cells were preincubated for 24 h with either RPMI (negative control),
-glucan (1 g/ml) (positive control), or serial dilutions of Pam3CSK4
(100 g/ml to 0.01 pg/ml), LPS (100 ng/ml to 105 pg/ml), flagellin (10
g/ml to 0.01 pg/ml), poly(I·C) (100 g/ml to 0.01 pg/ml), R848 (100
g/ml to 0.01 pg/ml), CpG (10g/ml to 0.001 pg/ml), Tri-DAP (10g/ml
to 0.001 pg/ml), and muramyl dipeptide (MDP) (10g/ml to 0.01 pg/ml)
for 24 h. After the first incubation, monocytes were washed with warm
PBS and maintained in RPMI supplemented with 10% pooled human
blood serum for 5 days (medium was refreshed at day 3). Thereafter, the
cells were subjected to a second stimulation of cytokine production with
LPS (10 ng/ml), Pam3CSK4 (10 g/ml), or RPMI (negative control).
After 24 h, duplicate supernatants were collected, pooled, and stored at
20°C until assayed.
To investigate whether various inhibitors affect training, the adherent
monocytes were preincubated for 1 h prior to the first stimulation with
p38 inhibitor (1 M), Syk inhibitor (140 M), JNK inhibitor (20 M),
ERK inhibitor (10M), MTA (1 mM), EGCG (15M), pargyline (3M),
or ITF2357/9 (100 nM). Subsequently, the microbial stimuli were added
to the cells with the inhibitors for an additional 24 h. Thereafter, the cells
were washed with PBS and further incubated for 5 days in culture medium
supplemented with 10% pooled human serum. On day 6, the trained
macrophages were subjected to a second stimulation for 24 h with either
LPS or Pam3CSK4. The supernatants were collected and stored at20°C
until assessed.
Cytokine assay. The concentrations of tumor necrosis factor alpha
(TNF-) (R&D Systems, Abingdon, United Kingdom) and interleukin 6
(IL-6) (Sanquin, Amsterdam, Netherlands) were measured in cell culture
supernatants 24 h after the second stimulation using an enzyme-linked
immunosorbent assay (ELISA), according to the manufacturer’s instruc-
tions.
Lactate hydrogenase (LDH) measurements were performed with the
CytoTox 96 nonradioactive cytotoxicity assay (Promega), according to
the manufacturer’s instructions. Briefly, the adherent monocytes were
incubated for 24 h with different microbial ligands, and the secreted LDH
was measured in the cell culture supernatants. To check for putative
cytotoxic effects of mitogen-activated protein kinase (MAPK), Syk, and
epigenetic inhibitors, the adherent monocytes were incubated for 24 h
with RPMI, MAPK, Syk, or epigenetic inhibitors. Thereafter, the super-
natants and cells were collected and stored until assessed. The values of the
inhibitors in RPMI were considered to be background and subsequently
subtracted from the final results. RPMI was considered a negative control.
The final values are depicted in percentages.
Extracellular cytokine staining and flow cytometry. Three milliliters
of PBMCs with a concentration of 5 106 cells/ml was cultured in a well
of a 6-well plate. After 1 h of incubation at 37°C and 5% CO2, the nonad-
TABLE 1 Pattern recognition receptors and microbial ligands and their
adapter molecules
PRR Microbial ligandsa
Adapter
moleculeb
Membrane receptors
Dectin-1 -glucan CARD9
TLR2 Lipoteichoic acid (Pam3CSK4) TIRAP
Lipoproteins MyD88
Glycosyl-phosphatidylinositols
from Toxoplasma gondii
TLR4 Lipopolysaccharide TIRAP
Envelope proteins of RSV MyD88
Glycosyl-phosphatidylinositols
from T. gondii
TRAM
TRIF
TLR5 Flagellin MyD88
Endosomal receptors
TLR3 dsRNA TRIF
Poly (I·C)
TLR7/8 ssRNA (R848) MyD88
TLR9 CpG DNA MyD88
Cytosolic receptors
NOD1 Tri-DAP CARD6
NOD2 Muramyl dipeptide CARD12
a RSV, respiratory syncytial virus; dsRNA, double-stranded RNA; ssRNA, single-
stranded RNA.
b TRAM, Toll-like receptor adaptor molecule.
Differential Cytokine Induction by PRR Families
April 2014 Volume 21 Number 4 cvi.asm.org 535
 o
n
 February 4, 2015 by University of Aberdeen
http://cvi.asm
.org/
D
ow
nloaded from
 
herent cells were washed 3 times with warm PBS. The remaining adherent
monocytes were prestimulated for 24 h with concentrations of different
ligands that would induce either training or tolerance, such as-glucan (1
g/ml), MDP (1g/ml), flagellin (1g/ml), R848 (1g/ml), Pam3CSK4
(1 g/ml), and RPMI (negative control). The stimuli were washed away
and the cells were further incubated for 5 days in the presence of RPMI
supplemented with 10% pooled human serum. On day 7, the cells were
incubated for 1 h with Versene solution, collected, harvested by centrifu-
gation, and suspended in PBS supplemented with 1% protein blocking
agent (PBA). The cells were washed two times and stained extracellularly
with the following antibodies: anti-CD45-PeCy7 (Beckman Coulter),
anti-CD68-APC (BioLegend), anti-CD14-PE (Beckman Coulter), anti-
CD11b-FITC (Beckman Coulter), and anti-DC-SIGN-APC (BioLegend).
The samples were measured on a fluorescence-activated cell sorter
(FACS) FC500, and the data were analyzed using the CXP software (Beck-
man Coulter).
Statistical analysis. IBM SPSS Statistics software, version 20, was used
to perform statistical analysis. All experiments were performed at least
three times, with a minimum of six volunteers. In order to assess
the training effect of a specific ligand upon a secondary stimulation,
nontrained cells stimulated with LPS (or Pam3CSK4) were compared
with trained cells restimulated with LPS (or Pam3CSK4). Differences be-
tween the groups were analyzed using the Wilcoxon signed-rank test and
were considered statistically significant at a P value of	0.05.
RESULTS
Type of ligand-PRR interactions and pathogen-associated mo-
lecular pattern concentration decides the inflammatory state of
monocytes. Some microbial ligands, such as-1,3-glucan (-glu-
can) and the muramyl dipeptide (MDP) component of pepti-
doglycans, induce trained immunity through the engagement of
dectin-1 and nucleotide-binding oligomerization domain 2
(NOD2), respectively (16, 17), while the TLR4 agonist, LPS, in-
duces tolerance (19, 20). We performed a systematic assessment to
determine whether exposure of adherent monocytes to the micro-
bial ligands of the TLR and NOD-like receptor (NLR) classes of
pattern recognition receptors, such as Pam3CSK4, LPS, flagellin,
poly(I·C), R848, CpG, and Tri-DAP, also influences the cell re-
sponse to a secondary stimulation. The adherent monocytes were
therefore exposed to each different PRR ligand for 24 h (first stim-
ulus) at a concentration that would induce an inflammatory re-
sponse, followed by a washout step. Following a resting time of 5
days, a period during which monocytes in the absence of any pri-
mary event differentiate into macrophages, the cells were exposed
to a secondary stimulation with either LPS or Pam3CSK4 (second
stimulus) (Fig. 1A).
The Candida albicans cell wall component -glucan strongly
trains monocytes, leading to an enhanced production of TNF-
and IL-6 upon nonspecific secondary stimulation with LPS or
Pam3CSK4 (16); therefore,-glucan preincubation of monocytes
was used as an inherent control of effective training throughout
this study (Fig. 1B). In contrast to the training obtained upon
engagement of dectin-1, the stimulation of the membrane recep-
tors TLR2, TLR4, and TLR5 by inflammatory doses of Pam3CSK4
(100g/ml), LPS (100 ng/ml), and flagellin (10g/ml) induced a
long-term tolerant state in which monocytes produced fewer pro-
inflammatory cytokines (TNF- and IL-6) upon restimulation
than did the RPMI-treated control cells (Fig. 1C to E). Although
LPS tolerance has been described in vitro (21) and in vivo (27) in
short-term experiments, no studies have assessed the long-term
effects of LPS. Using our training model of human adherent
monocytes, we described a long-term tolerance effect of LPS (100
ng/ml) on the cytokine production observed upon secondary
stimulation. In contrast to the membrane-associated TLRs, en-
gaging cytosolic PRRs during the primary exposure to pure li-
gands revealed more diverse outcomes in terms of innate immune
memory features. Preactivation of the endosomal TLR3 with a
strong inflammatory dose of poly(I·C) (100 g/ml) maintained
the cells in a tolerant status, being refractory to the second stimu-
lation (Fig. 2A). Similarly, engagement of the endosomal TLR7/8
with R848 (100 g/ml) also induced a refractory state of mono-
cytes for TNF- but not for IL-6 (Fig. 2B). However, the use of
CpG (10 g/ml) for preactivating TLR9 failed to induce any
trained or tolerant effect (Fig. 2C). In contrast, the engagement of
NOD1 by Tri-DAP (10 g/ml) and NOD2 by MDP (10 g/ml)
significantly trained the cells toward an increased production of
TNF- and IL-6 (Fig. 2D and E). Of note, while no correlation was
observed between the trained or refractory status obtained and the
intracellular adapter molecules of TLRs (i.e., MyD88, Toll-inter-
leukin 1 receptor [TIR] domain-containing adaptor protein
[TIRAP], and TIR domain-containing adapter-inducing beta in-
terferon [TRIF]) (Table 1), it seemed that engaging receptors that
signal through caspase recruitment domain (CARD) molecules
favored an enhanced trained immunity status. Altogether, the ac-
tivation of TLRs present at the cell surface seemed to maintain the
cells in a refractory status. However, engaging endosomal TLRs
had a striking and different effect on the functional fate of mono-
cytes, regardless of the adaptor molecules that were used to signal.
Finally, engaging cytosolic NLRs seemed to result in an enhanced
proinflammatory immune status.
In order to assess whether the ligand concentration influences
the training of monocytes, titrations of all the ligands assessed in
this study were performed. None of the first incubations with low
doses of ligands induced measurable amounts of proinflamma-
tory cytokines in the supernatants collected after the first 24 h
(data not shown). We first deciphered the titration response of the
cell membrane-associated TLRs. Systematically lowering the
amount of Pam3CSK4, which is used to activate the cell mem-
brane-associated TLR2, strongly modified the monocyte repro-
gramming characteristics. Pam3CSK4 in a low concentration (1
g/ml) resulted in a tolerance status for TNF- and IL-6 upon
LPS secondary stimulation. Interestingly, upon restimulation
with Pam3CSK4, Pam3CSK4-preactivated monocytes were pro-
grammed to produce an increased amount of IL-6 compared to
that produced by nonactivated (RPMI) control cells (Fig. 3A). The
anti-inflammatory-trained pattern was generally observable for
TNF- upon LPS secondary stimulation (Fig. 3A). Similarly, de-
creasing the amount of LPS and flagellin during the preactivation
period of monocytes led to the opposite effect of tolerance, which
is a proinflammatory status represented by significantly elevated
levels of TNF- and IL-6 upon restimulation (Fig. 3B and C).
We next deciphered the effect of differential engagement of
cytosolic receptors. Preincubation of cells with low doses of
poly(I·C) or R848 gradually reversed the long-term tolerance ef-
fect (Fig. 4A and B), leading to a training effect upon restimulation
with LPS or Pam3CSK4. Interestingly, lowering the concentra-
tions of CpG (Fig. 4C), Tri-DAP (Fig. 4D), or MDP (Fig. 4E) did
not reverse the long-term effect obtained with high inflammatory
doses. Particularly, lowering the doses of CpG did not alter the
“inert” status of priming, and none of the doses used triggered an
enhanced or refractory immune status upon restimulation of the
monocytes (Fig. 4C). However, although the enhanced proin-
Ifrim et al.
536 cvi.asm.org Clinical and Vaccine Immunology
 o
n
 February 4, 2015 by University of Aberdeen
http://cvi.asm
.org/
D
ow
nloaded from
 
flammatory status of the monocytes was not reversed to tolerance,
the training effect obtained with the preactivation of NLRs even-
tually vanished by lowering the amount of Tri-DAP and MDP,
resulting in normal nontolerant and nontrained cells (Fig. 4D and
E). Cell viability and ligand toxicity were assessed at 24 h and at 7
days after the first stimulation for all the ligands tested, and none
of the ligands used during the 24 h of primary cell stimulation
enhanced LDH release compared to RPMI-treated cells (see Fig.
S1 in the supplemental material), demonstrating that the de-
creased cytokine production was not due to the toxicity of the
ligands used in the experiments.
Trained or tolerized cells exhibit a broad range of cell size,
granulocity, and different macrophage markers at the surface.
Macroscopically, cells trained with -glucan (1 g/ml), MDP (1
g/ml), and flagellin (1 g/ml) are considerably larger than non-
treated cells (Fig. 5A to D), while macrophages that entered a
tolerized status were comparable in size to RPMI-treated cells
(Fig. 5E and F). The phenotype of considerably larger trained cells
is reminiscent of a previous study by Daigneault et al. (28) in
which human monocyte-derived macrophages with serum and
PMA-activated-THP1 cells via activation showed increased light
scattering due to the accumulation of organelles (28). To establish
the similarities and differences between long-term innate immune
reprogramming by PRR ligands and the process of PMA-induced
cell activation, we assessed the effect of two different concentra-
tions of PMA (10g/ml and 10 ng/ml) in our in vitro experimental
model. Preincubating monocytes with a low dose of PMA (10
ng/ml) during the first 24 h resulted in an enhanced proinflam-
FIG 1 (A) In vitro training scheme. Adherent monocytes were incubated with pure ligands (training stimuli) for 24 h at 37°C. Following the first incubation, the
cells were washed with warm PBS and further incubated with RPMI and pooled human serum for 5 days. In the absence of any training stimulus during the first
24 h, primary monocytes maintained in culture for several days eventually differentiated into macrophages. After this resting period, different pattern recognition
receptor ligands were added (second stimulus) for an additional 24 h. (B to E) Tolerance induced by the membrane receptors. The cells were preexposed for 24
h to culture medium, -glucan (1 g/ml) (B), Pam3CSK4 (100 g/ml) (C), LPS (100 ng/ml) (D), or flagellin (10 g/ml) (E). Primary stimuli were washed out,
and after 6 days, the macrophages were restimulated with RPMI (negative control), LPS (10 ng/ml), or Pam3CSK4 (10g/ml). While-glucan induced training,
Pam3CSK4, LPS, and flagellin induced tolerance. The data are presented as means
 standard error of the mean (SEM) (n 8, from 5 independent experiments).
*, P	 0.05; **, P	 0.01; ***, P	 0.001; #, P	 0.05 (tolerance). The Wilcoxon signed-rank test was used to detect significant differences.
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matory status, while the higher concentration (10g/ml) induced
a refractory immune status compared to the nonactivated control
macrophages (see Fig. S2 in the supplemental material). Hence,
these results suggest the ability of PMA to induce differential ac-
tivation of monocytes at the level of proinflammatory cytokine
production and in a dose-dependent manner, similarly to TLR
ligands.
To further investigate the phenotype of trained versus tolerant
cells, we assessed several surface markers on the cells treated with
different pathogen-associated molecular patterns (PAMPs) by
means of flow cytometry (Fig. 6). Adherent monocytes were
trained as previously described (Fig. 1A), and after 6 days, cells
were restimulated with medium alone. All the counts were gated
on CD45 high cells (Fig. 6B and C). -glucan was used as an
inherent control; thus, based on -glucan-trained macrophages,
several cell populations were identified for CD14, CD68, and
DC-SIGN cells (Fig. 6D to F), while for CD11b cells, only one
cell population was identified (Fig. 6G). The levels of CD14,
CD68, DC-SIGN, and CD11b cells at the cell surface were
assessed. Interestingly, based on the side and forward scatter anal-
yses, all -glucan-trained cells proved to be of a broad granulocity
and size range, and most of the cells were positive for CD14, CD68,
and CD11b (Fig. 6H to J). Similar observations were obtained
with MDP- and flagellin-treated cells at a concentration that in-
duces training (1 g/ml) (Fig. 6H and J), while CD68 and DC-
SIGN cells were less present among the MDP- and flagellin-
trained cells. Tolerant macrophages treated with Pam3CSK4 (1
g/ml) or R848 (1 g/ml) were significantly smaller than -glu-
can-trained cells, with a broad granulocity, and fewer were posi-
tive for CD68, CD11b, or DC-SIGN, while CD14 was still present
to a similar intensity as -glucan-trained cells (Fig. 6H to K).
Trained immunity is dependent on MAP kinase-dependent
pathways and histone methylation and acetylation. MAP ki-
nases (MAPK) play a key role in the induction of the initial inflam-
matory cytokine response of the activated monocytes (29). This
prompted us to investigate whether MAPK (ERK, JNK, and p38)
and Syk pathways are involved in the training effects of mono-
cytes. While -glucan signaling induces trained immunity via the
noncanonical Raf1 pathway (16), we show here that p38 and JNK
are involved in the training of primary monocytes by MDP and
flagellin (Fig. 7A and B). In contrast, ERK and Syk inhibitors did
not affect training by these ligands (data not shown). -glucan-
and Mycobacterium bovis BCG-induced trained immunity is me-
diated by epigenetic mechanisms (16, 17). We assessed whether
histone modifications by methylation or acetylation influence the
observed training effects of MDP and flagellin. The inhibition of
histone methyltransferases with 5=-deoxy-5=-methylthioadenos-
ine (MTA) or inhibition of histone acetyltransferases with epigal-
locatechin-3-gallate (EGCG) drastically inhibited the training of
monocytes (Fig. 7C and D). In contrast, the inhibitors of histone
demethylase or deacetylase enzymes did not significantly influ-
ence the training effects of MDP or flagellin. Notably, the putative
cytotoxic effects of MAPK, Syk, and epigenetic inhibitors used in
the study were assessed by LDH measurements. None of the in-
hibitors used during the 24 h of primary cell stimulation enhanced
LDH release compared with RPMI-treated cells (see Fig. S3 in the
supplemental material), demonstrating that the molecules were
not toxic to the cells.
DISCUSSION
In the present study, we show that primary exposure to microbial
ligands alters the functional fate of monocytes, which is deter-
mined by the nature and concentrations of the PRRs engaged.
Engagement of NLRs (NOD2 or NOD1 receptors) induces trained
immunity, a long-term enhanced immune status upon priming
with high doses of MDP or Tri-DAP, which can vanish with
smaller amounts of ligands. The engagement of TLRs with high
inflammatory doses of PRR ligands predominantly induces toler-
ance, with the exception of CpG, for which tolerance seems to be
inherent at any dose assessed. Interestingly, low concentrations of
FIG 2 Differential effects of endosomal and cytosolic receptors on adherent
monocytes. The cells were preexposed for 24 h to culture medium, poly(I·C)
(100 g/ml) (A), R848 (100 g/ml) (B), CpG (10 g/ml) (C), Tri-DAP (10
g/ml) (D), and MDP (10 g/ml) (E). Primary stimuli were washed out, and
after 6 days, the macrophages were restimulated with RPMI (negative control),
LPS (10 ng/ml), or Pam3CSK4 (10g/ml). While poly(I·C) induced tolerance
for TNF- and IL-6, R848 was able to induce tolerance for TNF- only, and
CpG did not exert any significant effect on the inflammatory status of mono-
cytes. Both types of NLRs were able to enhance the status of monocytes upon a
second exposure to either LPS or Pam3CSK4. The data are presented as the
means
 SEM (n 8, from 5 independent experiments). *, P	 0.05; **, P	
0.01; ***, P 	 0.001; #, P 	 0.05 (tolerance). The Wilcoxon signed-rank test
was used to detect significant differences.
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TLR ligands not only abolished the tolerance-induced effect but
reversed it, and in fact, trained the monocytes to be maintained in
a heightened proinflammatory state. Furthermore, functional re-
programming of monocytes was also associated with cell shape
and cell surface marker modifications. Finally, training of mono-
cytes by MDP and flagellin is mediated by p38 and JNK MAPK-
dependent pathways and depends on epigenetic histone modifi-
cations.
Earlier studies have shown that -glucan recognition by
monocytes through dectin-1 and CR3 induces trained immunity
(30), which mediates protection to reinfection in a T-/B-cell-in-
dependent fashion (16). Similarly, BCG vaccination in human
volunteers induces epigenetic reprogramming of monocytes and
enhances secondary responses to microbial stimulation (17). In
this study, we report that differential engagement of PRRs and that
PMA activation of monocytes might result in either an enhanced
or refractory innate immune status. These findings raise an im-
portant conceptual question: what is the difference between a
stimulated cell, a differentiated macrophage, and a trained im-
mune cell? The difference can be defined at a molecular epigenetic
level: the unstimulated monocyte or macrophage is characterized
by the absence of cytokine production, with silent markers for
both histone acetylation and methylation. During cell activation
and active transcription, both histone methylation and histone
acetylation are present at the promoter and enhancer levels, po-
tentiating gene transcription. The trained cell has lost its acetyla-
tion markers and thus has lost active transcription (after an initial
stimulation). However, in a trained cell (in contrast to a naive
cell), the promoters of inflammatory genes are tagged by histone
methylation, which allows for an accelerated and stronger re-
sponse upon restimulation. We recently described the H3K4
methylation as a property of trained monocytes (16), and this
characteristic was confirmed in a landmark study by Ostuni et al.
(31) showing the kinetic events during macrophage training. The
authors proposed the name “latent enhancers” for the epigenetic
units determining cell training (31). The opposing process of
trained immunity is the innate immune tolerance, which has been
known for more than half a century and which was recently dem-
onstrated to be regulated by epigenetic events (21, 32, 33).
Despite the importance of innate immune training and toler-
ance, no systematic studies have attempted to define which micro-
bial ligands and pattern recognition receptors induce trained im-
munity or tolerance. In the present study, we screened the major
TLR and NLR microbial ligands for their capacity to induce either
training or tolerance. Although dose dependent, we identified im-
portant bacterial ligands, such as flagellin and MDP, which can
induce trained immunity. In flagellated bacteria, flagellin is one of
the major proteins in the cell, and mammals tend to have a strong
immune response to flagellin. This molecule is recognized in
mammals by Toll-like receptor 5 (34, 35). Immune responses to
flagellin have been proposed to play an important role in the
pathogenesis of inflammatory bowel diseases (36, 37). From this
perspective, the capacity of flagellin to induce trained immunity
and a more potent inflammatory response may have important
consequences for the pathogenesis of this disease. On the other
hand, our data may lead to the conclusion that flagellin represents
an important new type of adjuvant for improving vaccination, a
hypothesis that is supported by earlier studies showing that flagel-
FIG 3 Dose responses of membrane-bound receptors. The cells were preexposed for 24 h to culture medium or to different concentrations of Pam3CSK4 (100
g/ml to 0.01 pg/ml) (A), LPS (100 ng/ml to 105 pg/ml) (B), and flagellin (10 g/ml to 0.01 pg/ml) (C). The first stimuli were washed away, and adherent
monocytes were further incubated for 5 days in culture medium supplemented with 10% pooled human pool serum. At day 6, the cells were restimulated with
RPMI (negative control), LPS (10 ng/ml), or Pam3CKS4 (10 g/ml). Depending on the concentration used, after several days, cells entered either a trained or
tolerized status. The data are presented as the means 
 SEM (n 8, from 5 independent experiments), *, P	 0.05; **, P	 0.01; ***, P	 0.001; #, P	 0.05
(tolerance). The Wilcoxon signed-rank test was used to detect significant differences. TNF- and IL-6 from cells stimulated with RPMI were below the detection
limit.
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lin is an effective adjuvant for immunization against lethal respi-
ratory challenge with Yersinia pestis (38). Muramyl dipeptide is a
component of bacterial cell wall peptidoglycan that is recognized
by NOD2 (39), which is present in most bacterial species. The
importance of NOD2 in protection against inflammatory bowel
disease has been highlighted by the fact that particular mutations
in NOD2 are associated with susceptibility to Crohn’s disease (40,
41). Recently, it has been proposed that MDP functions as a mu-
cosal adjuvant that enhances the immunogenicity of virus-like
particles (42). Consequently, its capacity to induce trained immu-
nity may represent an important advantage in these settings.
In contrast, other microbial ligands, such as the TLR9 agonist
CpG, had little, if any, long-term effects on the function of mono-
cytes. This argues that only certain ligands at certain concentra-
tions are capable of inducing trained immunity. A particular in-
teresting finding is that TLRs in high doses, with the exception of
TLR9, consistently induced long-term tolerance to secondary
stimulation with bacterial ligands. These findings are supported
by earlier studies showing that the in vitro tolerance and cross-
tolerance phenomena might be induced via TLR2, TLR4, and
TLR9 (43). Additionally, it has been reported that TLR7/8 engage-
ment mediates short-term tolerance in mice both in vitro and in
vivo (44, 45). Further investigation of the mechanisms mediating
this effect is warranted, especially in light of the known immuno-
suppressive effects of viral infections (46, 47). The levels of several
activation markers at the cell surface were assessed. Based on the
FIG 4 Dose responses of endosomal and cytosolic receptors. The cells were preexposed for 24 h to culture medium or to different concentrations of poly(I·C)
(100g/ml to 0.01 pg/ml) (A), R848 (100g/ml to 0.01 pg/ml) (B), CpG (10g/ml to 0.001 pg/ml) (C), Tri-DAP (10g/ml to 0.001 pg/ml) (D), and MDP (10
g/ml to 0.01 pg/ml) (E). The first stimuli were washed away, and adherent monocytes were further incubated for 5 days in culture medium supplemented with
10% pooled human pool serum. At day 6, the cells were restimulated with RPMI (negative control), LPS (10 ng/ml), or Pam3CKS4 (10 g/ml). Depending on
concentration used, after several days, cells entered either a trained or tolerized status. The data are presented as the means
 SEM (n 8, from 5 independent
experiments), *, P	 0.05; **, P	 0.01; ***, P	 0.001; #, P	 0.05 (tolerance). Wilcoxon signed-rank test was used to detect significant differences. TNF- and
IL-6 from cells stimulated with RPMI were below the detection limit.
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side and forward scatter analyses, -glucan-, MDP-, and flagellin-
trained cells are of a broad granulocity and cell size and mainly
positive for CD14 and CD11b, while cells positive for CD68 and
DC-SIGN were less present. Tolerant macrophages, treated with
Pam3CSK4 or R848, were significantly smaller than -glucan-
trained cells, and fewer were positive for CD68, CD11b, or DC-
SIGN, while the activation marker CD14 was still present on these
cells. No clear effect was seen on the expression of DC-SIGN on
the macrophages. The increase or decrease in these activation
markers might thus contribute to an increase or decrease, respec-
tively, in the innate immune responses during the induction of
trained immunity; nonetheless, future studies are warranted in
order to prove this. In addition, one may also speculate that
trained cells present different classes of activation markers than
FIG 5 Morphology of trained versus tolerized cells. The cells were preexposed for 24 h to culture medium (A) or to several pure ligands, such as -glucan (1
g/ml) (B), MDP (1 g/ml) (C), flagellin (1 g/ml) (D), R848 (1 g/ml) (E), and Pam3CSK4 (1 g/ml) (F). The first stimuli were washed away, and adherent
monocytes were further incubated for 5 days in culture medium supplemented with 10% pooled human pool serum. At day 6, the cells were microscopically
examined and representative pictures were chosen (200). After several days in culture, primary monocytes differentiated into the macrophages. While trained
cells appeared to be bigger and more activated (B, to D), cells that entered a tolerizing status seemed to be considerably smaller (E and F).
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FIG 6 Flow cytometric analysis of CD14-, CD68-, DC-SIGN-, and CD11b-positive cells gated on CD45 populations after prestimulation with-glucan, MDP,
flagellin, R848, and Pam3CSK4. A total of 3 ml at 5 106 PBMCs was incubated for 1 h, washed 3 times with PBS, and the remaining adherent monocytes were
coincubated with -glucan (1g/ml), MDP (1g/ml), flagellin (1g/ml), R848 (1g/ml), and Pam3CSK4 (1g/ml), or with RPMI (untrained control) for 24
h. Thereafter, the cells were washed and further incubated with RPMI supplemented with 10% pooled human serum for 5 days. At day 6, the macrophages were
incubated with Versene solution for 1 h at 37°C, detached from the plate, and stained extracellularly using anti-CD45 PECy7, anti-CD14 PE, anti-CD68 APC,
anti-DC-SIGN APC, and anti-CD11b FITC antibody. (A) The side scatter (SS) and forward scatter (FS) of the RPMI-treated cells are shown. (B and C) One
representative picture of the staining and gating on CD45 high -glucan-trained cells is shown. Depending on the fluorescence intensity as well as cell size, we
identified several cell populations, depicted as negative (), positive (), and high positive (). Gating on different populations of CD14 -glucan-trained
cells (D), CD68 -glucan-trained cells (E), DC-SIGN -glucan-trained cells (F), and CD11b -glucan-trained cells (G) are shown. (H to K) % of positive
cells gated on CD45 high. The data are presented as the means
 SEM (n 2, from 4 independent experiments).
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tolerized cells, depending on the subclasses of macrophages in-
duced upon prestimulation.
An important question regarding trained immunity refers to
the signaling and molecular mechanisms responsible for its induc-
tion. MAP kinases, such as p38, JNK, or ERK, are known to be
crucial signaling pathways mediating the stimulation of inflam-
matory mediators (48, 49), with the p38MAPK pathway being
critical for normal inflammatory responses in vivo (50). Notably,
the TRIF-dependent late-phase activation of the p38MAPK/MK2
pathway has been demonstrated to be essential for the transla-
tional control of TNF- production (51). LPS regulates the tran-
script stability of TNF- (52, 53) via activation of the p38MAPK/
MK2 pathway. Considering these crucial biological functions of
MAPKs, we assessed their role in the induction of trained immu-
nity. Our data demonstrate that JNK and p38 MAPK are central
for the induction of trained immunity by flagellin and MDP, and
they might represent potential therapeutic targets for clinical sit-
uations in which trained immunity mediates a long-term inflam-
matory response. In contrast, ERK and Syk do not seem to be
needed to elicit trained immunity.
Dynamic chromatin changes across immunological pathways
participate in the training mechanism induced by the preincuba-
tion of monocytes with -glucan (16). Exposure of monocytes to
-glucans induces high levels of H3K4 trimethylation at the pro-
moter level of inflammatory genes, which correlates with long-
term increased production of proinflammatory cytokines in
-glucan-trained monocytes, a hallmark of trained immunity
(16). The blockade of histone methylation or histone acetylation
inhibits trained immunity; the first of these modifications has
been associated with a state of transcriptional priming, while the
latter is associated with actual mRNA transcription. Similar mech-
anisms of epigenetic memory have been demonstrated in plants
during the phenomenon of systemic acquired resistance (54) and
may be involved in the resistance to reinfection in invertebrates
(55); both classes of organisms are devoid of adaptive immune
responses. Thus, the present study demonstrates that even in the
presence of adaptive immunity, the training of innate immunity is
operational and serves to enhance resistance to certain types of
infection.
A key aspect for consideration is that of the duration of trained
immunity effects in vivo and their potential impact on hematopoi-
etic stem cells. We recently demonstrated trained immunity ef-
fects of BCG on monocytes for up to 3 months after vaccination
(17). Considering the fact that circulating monocytes have a short
half-life of only days, this implies training effects of vaccination on
monocyte progenitor cells, and future studies are warranted to
assess this important aspect. Moreover, future studies should also
assess whether the direct contact of monocytes with microbial
ligands is absolutely necessary for the induction of trained immu-
nity, or whether soluble factors, such as cytokines, may also induce
similar effects in certain circumstances. In addition, one should
also keep in mind that classical monocyte differentiation into
FIG 7 (A and B) MAP kinase-dependent pathways mediate trained immunity. Adherent monocytes were preincubated for 1 h with culture medium, p38, ERK,
JNK, or Syk inhibitor (inh). After this inhibition period, 100 l per well of either culture medium, flagellin (1 g/ml), or MPD (1 g/ml) was added to the cell
suspension, without removing the inhibitors, for 24 h. Thereafter, the cells were washed and incubated with RPMI and 10% pooled human serum. At day 6, the
cells were subjected to a second stimulation with LPS (10 ng/ml) for an additional 24 h. The data are presented as the means
 SEM (n 7, from four independent
experiments). *, P 	0.05. The Wilcoxon signed-rank test was used to detect significant differences. (C and D) Blocking histone methylation and acetylation
inhibits trained immunity induced by MDP and flagellin. Before training, adherent monocytes were preincubated for 1 h with culture medium or with different
epigenetic inhibitors, such as histone methyltransferase inhibitor (MTA), histone acetyltransferase inhibitor (EGCG), histone demethylase inhibitor (pargyline),
and the histone deacetylase inhibitor ITF2357/9. Thereafter, 100 l of culture medium, -glucan (10 g/ml), flagellin (1 g/ml), or MPD (1 g/ml) was added
to the cell suspension, without removing the inhibitors, and further incubated for an additional 24 h. At day 6, the macrophages were subjected to a second
stimulation with LPS (10 ng/ml) for another 24 h. The data are presented as the means
 SEM (n 6, from three independent experiments), *, P	 0.05. The
Wilcoxon signed-rank test was used to detect significant differences.
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macrophages also implies epigenetic changes. However, there are
fundamental differences between the epigenetic elements in dif-
ferentiation versus training of monocytes: in the classical differ-
entiation, both histone methylation and acetylation epigenetic
markers lead to the expression of proteins that are characteristic of
a macrophage; in the training state, histone acetylation markers
are lost, and the promoters of certain genes retain only the histone
methylation markers characteristic of latent enhancers (31). These
latent enhancers will determine the increased transcription of
those genes only after cell stimulation. It can be also envisaged that
in certain situations, both training and differentiation markers
can be induced, with their respective functional consequences.
Our data have a number of broad implications. By inducing
long-term changes in cell capacity to respond to different patho-
gens, the processes of trained immunity and tolerance might have
important effects on the susceptibility of a host to infections. Sub-
sequently, a logical possibility is that the microorganisms encoun-
tered by the host on a regular basis may serve to differentiate and
continually renew a pool of memory-like macrophages that have
enhanced responses to an infectious challenge. By identifying the
receptors and signaling pathways that determine the functional
fates of monocytes and macrophages, our findings have the po-
tential to lead to the development of new therapeutics that can
harness both the potential of trained immunity to induce robust
responses to enhance pathogen defenses and of immune tolerance
to inhibit autoimmune phenomena.
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